Skip to content

Clinical trials

Withdrawn Observational Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Status: Withdrawn Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20111
20131
20141
20181
20192
20202
20213
20221
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Nice1
Charite University, Berlin, Germany1
East Tennessee State University1
Massachusetts General Hospital1
Medical College of Wisconsin1
Northwestern University1
Ohio State University1
ProgenaBiome1
Sunnybrook Health Sciences Centre1
Tammie L. S. Benzinger, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Cognitive Dysfunction5
Dementia4
Amyotrophic Lateral Sclerosis1
Brain Diseases1
COVID-191
Cerebral Amyloid Angiopathy1
Chronic Traumatic Encephalopathy1
Deglutition Disorders1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.